Cleared Traditional

K052119 - TESLAGUARD, MODEL EFT G04

K052119 is an FDA 510(k) clearance for TESLAGUARD, manufactured by Mammendorfer Institute For Physics & Medicine GmbH. The device is a Class 2 Cardiovascular device with product code MWI cleared through the Traditional 510(k) pathway after a 152-day FDA review.

K052119 · Mammendorfer Institute For Physics & Medicine GmbH · Cardiovascular device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Jan 2006
Decision
152d
Days
Class 2
Risk

K052119 is an FDA 510(k) clearance for the TESLAGUARD, MODEL EFT G04. Classified as Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms) (product code MWI), Class II - Special Controls.

Submitted by Mammendorfer Institute For Physics & Medicine GmbH (Golden, US). The FDA issued a Cleared decision on January 3, 2006 after a review of 152 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2300 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K052119

510(k) Number K052119 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 04, 2005
Decision Date January 03, 2006
Days to Decision 152 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
27d slower than avg
Panel avg: 125d · This submission: 152d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MWI Device Classification - Class 2, Special Controls

Product Code MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)

All 307
Devices cleared under the same product code (MWI) and FDA review panel - the closest regulatory comparables to K052119.
BIOSIGN
K053112 · Oxford Biosignals Limited · Jan 2006
STELLAR 404T
K060058 · Larsen & Toubro Limited · Jan 2006
3160 MRI PATIENT MONITORING SYSTEM
K053462 · Invivo Corporation · Jan 2006
MODEL 750E SERIES MONITOR
K051896 · Cas Medical Systems, Inc. · Dec 2005
VSM VITAL SIGNS MONITOR, MODEL 53000 (VSM 300)
K053027 · Welch Allyn, Inc. · Nov 2005
MRI COMPATIBLE PATIENT MONITORING SYSTEM, MODEL 3160
K050399 · Invivo Research, Inc. · Aug 2005